Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31064743 | 0.63 | SLC6A3 (0.40) | CYP19A1 | |
| SCHEMBL16000715 | 0.57 | LMNA (0.50) | — | |
| SCHEMBL29219505 | 0.57 | LMNA (0.50) | — | |
| SCHEMBL13915049 | 0.52 | — | — | |
| Adamantane SCHEMBL27851735 | 0.47 | CA5A (0.50) | — | |
| Sulfuric Acid SCHEMBL11235576 | 0.46 | — | — | |
| Sulfuric Acid SCHEMBL27946758 | 0.46 | CA5A (0.86) | — | |
| Sulfuric Acid SCHEMBL32784 | 0.46 | — | — | |
| Sulfuric Acid SCHEMBL4533776 | 0.46 | CA5A (0.86) | — | |
| SCHEMBL31257847 | 0.45 | TSHR (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-7031869-A | — | — | None | — | — | JP | disclosed |
| CN-101981665-B | Surface-modified colloidal silica and polishing composition for chemical mechanical polishing containing the same | ADEKA CORP | 2012-11-21 | — | — | CN | disclosed |
| US-8088537-B2 | Resist top coat composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2012-01-03 | — | — | US | disclosed |
| US-7915318-B2 | Aqueous ROMP-based monolith materials and methods for making | GENERAL ELECTRIC COMPANY (US) | 2011-03-29 | — | — | US | disclosed |
| CN-101981665-A | Surface-modified colloidal silica and polishing composition for chemical mechanical polishing containing the same | ADEKA CORP | 2011-02-23 | — | — | CN | disclosed |
| US-20100063200-A1 | AQUEOUS ROMP-BASED MONOLITH MATERIALS AND METHODS FOR MAKING | GENERAL ELECTRIC COMPANY (US) | 2010-03-11 | — | — | US | disclosed |
| US-20090197200-A1 | Resist top coat composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2009-08-06 | — | — | US | disclosed |
| US-20080306230-A1 | Composition and Associated Method | GENERAL ELECTRIC COMPANY (US) | 2008-12-11 | — | — | US | disclosed |
| US-6869744-B2 | Chemically amplified positive resist composition | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2005-03-22 | — | — | US | disclosed |
| US-20040161710-A1 | Pattern formation method | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. | 2004-08-19 | — | — | US | disclosed |
| US-20040162337-A1 | Lactone-type acidic compounds | CITY UNIVERSITY OF HONG KONG (HK) | 2004-08-19 | — | — | US | disclosed |
| US-20020042017-A1 | Chemically amplified positive resist composition | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-04-11 | — | — | US | disclosed |
| JP-H0731869-A | MICROCAPSULATION OF SOLID PARTICLE | JAPAN SYNTHETIC RUBBER CO LTD | 1995-02-03 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040162337-A1 | Lactone-type acidic compounds | ACSL1, ELOVL1, FASN | CYP19A1 40/4885 |
| US-20080306230-A1 | Composition and Associated Method | COX6C, GRIA4, CYCS | CYP19A1 1488/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.